Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Current Deferred Revenue (2013 - 2026)

Omnicell's (OMCL) quarterly Current Deferred Revenue came in at $247.9 million in Q2 2026, up 5.92% year-over-year from $234.0 million in Q2 2025, and down 9.84% quarter-over-quarter from $275.0 million in Q1 2026.

Analysis

Omnicell (OMCL) Current Deferred Revenue (2013 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Current Deferred Revenue for 14 consecutive years, with $247.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Current Deferred Revenue rose 5.92% year-over-year to $247.9 million in Q2 2026; TTM through Jun 2026 was $247.9 million, a 5.92% increase from a year earlier, with the FY2025 full-year figure at $235.1 million, up 8.1% from the prior year.
  • Current Deferred Revenue was $247.9 million for Q2 2026 at Omnicell, down from $275.0 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $275.0 million in Q1 2026 and troughed at $132.8 million in Q2 2022.
  • A 5-year average of $204.0 million and a median of $217.9 million in 2024 frame the typical range for Current Deferred Revenue.
  • Across the five-year window, Current Deferred Revenue dropped 0.31% in 2022 and surged 30.57% in 2023, its largest moves.
  • Over 5 years, Current Deferred Revenue stood at $156.3 million in 2022, then rose by 15.37% to $180.4 million in 2023, then grew by 20.59% to $217.5 million in 2024, then advanced by 8.1% to $235.1 million in 2025, then rose by 5.43% to $247.9 million in 2026.
  • The last three Current Deferred Revenue figures came in at $247.9 million (Q2 2026), $275.0 million (Q1 2026), and $235.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 247.89 Mn
Mar 31, 2026 274.96 Mn
Dec 31, 2025 235.12 Mn
Sep 30, 2025 245.50 Mn
Jun 30, 2025 234.04 Mn
Mar 31, 2025 238.37 Mn
Dec 31, 2024 217.49 Mn
Sep 30, 2024 222.18 Mn
Jun 30, 2024 218.25 Mn
Mar 31, 2024 229.78 Mn
Dec 31, 2023 180.36 Mn
Sep 30, 2023 180.04 Mn
Jun 30, 2023 173.35 Mn
Mar 31, 2023 185.74 Mn
Dec 31, 2022 156.33 Mn
Sep 30, 2022 148.44 Mn
Jun 30, 2022 132.77 Mn
Mar 31, 2022 152.04 Mn
Dec 31, 2021 132.40 Mn
Sep 30, 2021 128.87 Mn